NuCana plc Banner Image

NuCana plc

  • Ticker NCNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
NuCana plc Logo Image
  • 11-50 Employees
  • Based in Edinburgh, Scotland
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying their ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain part of the standard of care for the treatment of many solidMore and hematological tumors, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilizing their proprietary technology, they are developing new medicines, ProTides, designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. NuCana’s robust pipeline includes three ProTides in clinical development.
4.8 / 5.0 (101)

NuCana plc reports have an aggregate usefulness score of 4.8 based on 101 reviews.

NuCana plc

Most Recent Annual Report

NuCana plc
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

NuCana plc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!